帕金森病中的多神经病非常普遍,与治疗无关
Valeria Sajin1, Uwe Jahnke2, Uazman Alam3
1Neurology and Neurophysiology Department, Schön Klinik Neustadt, Neustadt in Holstein, Germany; Neurology Department, Asklepios Klinik Sankt Georg, Hamburg, Germany.
Clinical therapeutics
|December 28, 2024
概括
周围多神经病 (PN) 在帕金森病 (PD) 中很常见,影响超过70%的患者. 这项研究没有发现PN和Levodopa治疗之间的联系,这表明PD患者的PN的其他原因.
科学领域:
- 神经学 神经学
- 临床神经生理学 临床神经生理学
背景情况:
- 外围多神经病 (PN) 在帕金森病 (PD) 中越来越多地被认可.
- 利沃多巴治疗被怀疑是PD患者PN发展的贡献者.
- 了解PD中PN的患病率和特征对于患者管理至关重要.
研究的目的:
- 确定PD患者在现实世界队列中的PN的流行率和临床特征.
- 调查口服乐伏多巴与PD中PN发生的潜在关联.
- 评估PN对PD患者功能障碍的影响.
主要方法:
- 对692名连续异常病理PD患者进行了回顾性横截面研究.
- 患者接受了临床,实验室和下肢神经生理学评估.
- 分析了数据,以确定PN的流行率,并将其与患者人口统计和药物使用相关联.
主要成果:
- 超过73%的PD患者表现出神经病变的临床症状,PN在显著比例上被电生理学证实.
- 中度至重度的感官轴突PN在一半受影响的患者中被诊断出来.
- 在口服乐伏多巴或其他多巴胺类药物的每日剂量与PN的存在之间没有发现显著的关联.
结论:
- 外围多神经病在帕金森病患者中非常普遍.
- 口服利沃多巴和其他多巴胺类药物似乎与PD中的PN无关.
- 进一步研究PD中PN的病理生理学是有必要的,同时提高临床意识.
更多相关视频
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
7.4K
08:09Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
7.5K
相关概念视频
Parkinson's Disease: Treatment
216
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
216
Parkinson's Disease: Overview
476
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
476
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
